Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sumatriptan
Therapeutic Area : Neurology
Study Phase : Phase I
Recipient : Sorrento Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable
Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)
Details : Sumatriptan Succinate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Migraine Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 26, 2017
Lead Product(s) : Sumatriptan
Therapeutic Area : Neurology
Highest Development Status : Phase I
Recipient : Sorrento Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigation of the Effect of the Female Urinary Microbiome on Incontinence
Details : Estrogen is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Urinary Bladder, Overactive.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 18, 2016
Lead Product(s) : Lactobacillus
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : London Health Sciences Centre Research Institute (Lawson) | Western University, Canada | Integrated Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14
Details : Lactobacillus is a Probiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Vaginosis, Bacterial.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
May 15, 2014
Lead Product(s) : Lactobacillus
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : London Health Sciences Centre Research Institute (Lawson) | Western University, Canada | Integrated Research
Deal Size : Inapplicable
Deal Type : Inapplicable